Laxeertabletten Bisacodyl Htp

Bisacodyl, the active ingredient in Laxeertabletten Bisacodyl Htp, is a stimulant laxative presented as a tablet for oral use. It treats constipation in adults and children as directed by a healthcare professional.

GNH USA supplies Laxeertabletten Bisacodyl Htp as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bisacodyl is a stimulant laxative used to relieve constipation by enhancing colonic motility.

- Constipation: provides relief of occasional constipation and facilitates regular bowel movements. - Bowel preparation: aids in cleansing the colon prior to diagnostic examinations such as colonoscopy. - Post‑operative ileus: helps stimulate intestinal motility after surgery when indicated by a physician.

Bisacodyl may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps or pain. - Diarrhea or loose stools. - Nausea or mild vomiting. - Thirst or increased fluid loss. - Flatulence or bloating. - Urgency to defecate.

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance. - Allergic reactions such as rash, itching or swelling. - Rectal bleeding or severe abdominal pain indicating possible colonic injury. - Rare cases of colonic perforation. - Persistent vomiting or inability to tolerate oral intake.

Before using bisacodyl, consider the following safety measures.

- Assess renal function: adjust use in patients with impaired kidney function. - Monitor electrolyte status: prolonged use may lead to imbalances. - Avoid in acute abdominal conditions: do not use when obstruction or acute abdomen is suspected. - Limit duration: restrict to short‑term use unless a clinician advises otherwise. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Bisacodyl can interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Anticholinergic agents: may reduce the laxative effect. - Magnesium‑containing antacids: increase risk of excessive diarrhea. - Digitalis glycosides: electrolyte shifts may enhance toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: monitor for dehydration and electrolyte loss. - Corticosteroids: watch for fluid and electrolyte disturbances. - Lithium: observe lithium levels due to possible changes in renal clearance.